硫酸氯吡格雷结构式
|
常用名 | 硫酸氯吡格雷 | 英文名 | Clopidogrel bisulfate |
|---|---|---|---|---|
| CAS号 | 120202-66-6 | 分子量 | 419.900 | |
| 密度 | N/A | 沸点 | 423.7ºC at 760 mmHg | |
| 分子式 | C16H18ClNO6S2 | 熔点 | 184ºC | |
| MSDS | 中文版 美版 | 闪点 | 210ºC |
硫酸氯吡格雷用途Clopidogrel是一种抗血小板剂,阻止血小板粘在一起,防止它们形成有害的凝块。 |
| 中文名 | 硫酸氯吡格雷 |
|---|---|
| 英文名 | clopidogrel sulfate |
| 中文别名 | 硫酸氢氯吡格雷 | 氯吡格雷硫酸氢盐 | 氯吡格雷硫酸盐 | (S)-(+)-2-(2-氯苯基)-2-(6,7-二氢噻吩并[3,2-C]吡啶-5-基)乙酸甲酯硫酸盐 | (S)-(+)-氯吡格雷硫酸盐 | 硫酸氢氯吡格雷 II型 | 硫酸氢氯吡格雷 I | (S)-(+)-(2-氯苯基)-6,7-二氢噻吩并[3,2-c]吡啶-5(4H)乙酸甲酯硫酸氢盐 |
| 英文别名 | 更多 |
| 描述 | Clopidogrel是一种抗血小板剂,阻止血小板粘在一起,防止它们形成有害的凝块。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 沸点 | 423.7ºC at 760 mmHg |
|---|---|
| 熔点 | 184ºC |
| 分子式 | C16H18ClNO6S2 |
| 分子量 | 419.900 |
| 闪点 | 210ºC |
| 精确质量 | 419.026398 |
| PSA | 140.76000 |
| LogP | 3.96550 |
| InChIKey | FDEODCTUSIWGLK-RSAXXLAASA-N |
| SMILES | COC(=O)C(c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O |
| 外观性状 | solid | white |
| 储存条件 | 2-8°C |
| 水溶解性 | DMSO: ~26 mg/mL |
| 硫酸氯吡格雷上游产品 9 | |
|---|---|
| 硫酸氯吡格雷下游产品 2 | |
| 海关编码 | 2942000000 |
|---|
|
Environmental friendly method for urban wastewater monitoring of micropollutants defined in the Directive 2013/39/EU and Decision 2015/495/EU.
J. Chromatogr. A. 1418 , 140-9, (2015) The fate and removal of organic micropollutants in the environment is a demanding issue evidenced by the recent European policy. This work presents an analytical method for the trace quantification of... |
|
|
RASA3 is a critical inhibitor of RAP1-dependent platelet activation.
J. Clin. Invest. 125(4) , 1419-32, (2015) The small GTPase RAP1 is critical for platelet activation and thrombus formation. RAP1 activity in platelets is controlled by the GEF CalDAG-GEFI and an unknown regulator that operates downstream of t... |
|
|
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
Eur. J. Pharm. Sci. 78 , 47-53, (2015) Human arylacetamide deacetylase (AADAC) is an esterase responsible for the hydrolysis of some drugs, including flutamide, indiplon, phenacetin, and rifamycins. AADAC is highly expressed in the human l... |
| Methyl (S)-(+)-2-(2-Chlorophenyl)-2-[6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]acetate Sulfate |
| MFCD00876395 |
| Plavix |
| Clopidogrel sulfate |
| Clopidogrel Hydrogen sulfate |
| Methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate |
| methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate sulfate |
| methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate sulfate (1:1) |
| Clopidogrel bisulfate |
| (S)-(+)-Clopidogrel Sulfate |
| (2S)-(2-chlorophényl)(6,7-dihydrothiéno[3,2-c]pyridin-5(4H)-yl)éthanoate de méthyle sulfate |
| Clopidogrel Hydrogensulfate |
| Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-, sulfate (1:1) |
| (+)-Clopidogrel hydrogen sulfate |
| Clopidogrel bisulphate |
| (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate |
| Methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate (1:1) |
| a-(S)-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic Acid Methyl Ester Sulfate (1:1) |
| Methyl aS-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate Sulfate (1:1) |
| Methyl-(2S)-(2-chlorphenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoatsulfat |
| Clopidogrel |
| (S)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogensulfate |
| S-(+)-Clopidogrel Hydrogen Sulfate |
| Clopidogrel (hydrogen sulfate) |